This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Indiana University, University of Illinois. Active years: 2023-2024.
Company Filing History:
2 out of 809 
2 out of 2,424 
Years Active: 2023-2024
Title: Jason Ralph Hickok: Innovator in Pharmaceutical Research
Introduction
Jason Ralph Hickok is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of 2 patents, his work has the potential to impact the treatment of various health conditions.
Latest Patents
Hickok's latest patents focus on nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. These compounds are designed to act as inhibitors of NAMPT, which plays a crucial role in cellular metabolism. The methods for their use aim to treat or prevent diseases such as pulmonary arterial hypertension (PAH). The patents disclose compounds that include those of Formula (II) and their pharmaceutically acceptable salts, detailing the substituents involved.
Career Highlights
Throughout his career, Hickok has worked with prestigious institutions such as Indiana University and the University of Illinois. His research has contributed to advancements in understanding and treating complex diseases, showcasing his dedication to innovation in the pharmaceutical field.
Collaborations
Hickok has collaborated with notable colleagues, including Wrickban Mazumdar and Roberto F Machado. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.
Conclusion
Jason Ralph Hickok is a prominent inventor whose work in pharmaceutical research has led to significant advancements in the treatment of diseases. His innovative approach and dedication to research continue to influence the field positively.